Mild to Moderate Atopic Dermatitis (DBCOND0038357)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05057351	A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic Dermatitis	No drug interventions	treatment	Not Available	completed
NCT01079897	Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic Dermatitis	No drug interventions	treatment	Not Available	completed
NCT05729074	A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients	Pimecrolimus	treatment	1	not_yet_recruiting
NCT02079688	Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema	Aloe vera leaf Coconut oil Hyaluronic acid Propylene glycol Rosemary	treatment	2	completed
NCT03250663	Eucrisa for Atopic Dermatitis	Crisaborole	health_services_research	1	active_not_recruiting
NCT01568489	Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis	No drug interventions	treatment	2	completed
NCT00568412	A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis	Pimecrolimus	treatment	4	completed
NCT06052995	Observational Study to Evaluate Use of Elidel® in South and East Asian Pediatric Patients With Atopic Dermatitis.	Pimecrolimus	Not Available	Not Available	not_yet_recruiting
NCT00996008	CT 327 in the Treatment of Atopic Dermatitis	Pegcantratinib	treatment	2	terminated